297 related articles for article (PubMed ID: 27348830)
1. The Social Framework Surrounding the Development of Regenerative Medicine in Japan.
Nakazawa E; Takimoto Y; Akabayashi A
Camb Q Healthc Ethics; 2016 Jul; 25(3):466-71. PubMed ID: 27348830
[TBL] [Abstract][Full Text] [Related]
2. Accelerating regenerative medicine: the Japanese experiment in ethics and regulation.
Lysaght T
Regen Med; 2017 Sep; 12(6):657-668. PubMed ID: 28976822
[TBL] [Abstract][Full Text] [Related]
3. New Japanese initiatives on stem cell therapies.
Konomi K; Tobita M; Kimura K; Sato D
Cell Stem Cell; 2015 Apr; 16(4):350-2. PubMed ID: 25842974
[TBL] [Abstract][Full Text] [Related]
4. Stem cell research and regenerative medicine in 2014: first year of regenerative medicine in Japan.
Okano H
Stem Cells Dev; 2014 Sep; 23(18):2127-8. PubMed ID: 25192239
[TBL] [Abstract][Full Text] [Related]
5. Japanese Laws and the Current Status of Regenerative Medicine in the Tohoku Region.
Kamano Y; Terajima N; Chiba Y; Suresh VV; Saito M
J Contemp Dent Pract; 2023 Feb; 24(2):120-128. PubMed ID: 37272144
[TBL] [Abstract][Full Text] [Related]
6. Stem cells: intellectual property issues in regenerative medicine.
Zachariades NA
Stem Cells Dev; 2013 Dec; 22 Suppl 1(Suppl 1):59-62. PubMed ID: 24304078
[TBL] [Abstract][Full Text] [Related]
7. Regulatory perspectives of Japan.
Kusakabe T
Biologicals; 2015 Sep; 43(5):422-4. PubMed ID: 26028474
[TBL] [Abstract][Full Text] [Related]
8. Embryo-like features of induced pluripotent stem cells defy legal and ethical boundaries.
Meskus M; de Miguel Beriain I
Croat Med J; 2013 Dec; 54(6):589-91. PubMed ID: 24382856
[No Abstract] [Full Text] [Related]
9. Global update: Germany.
Lauter FR; Wirsching S
Regen Med; 2011 Nov; 6(6 Suppl):154-7. PubMed ID: 21999280
[TBL] [Abstract][Full Text] [Related]
10. Exploring innovation in stem cell and regenerative medicine in Japan: the power of the consortium-based approach.
Munisi HI; Xie Z; Sengoku S
Regen Med; 2014; 9(4):467-77. PubMed ID: 25159064
[TBL] [Abstract][Full Text] [Related]
11. How California Institute for Regenerative Medicine research programs support science and regulatory policy.
Lomax GP; DeWitt ND; Millan MT; Feigal EG
Stem Cells Transl Med; 2014 Jun; 3(6):673-4. PubMed ID: 24771395
[TBL] [Abstract][Full Text] [Related]
12. A Japanese Bioventure Company's Application of Stem Cell Technology in Regenerative Medicine.
Sawada M; Sugiyama D; Nii T; Konno K; Kagimoto HTS
Clin Ther; 2018 Nov; 40(11):1801-1806. PubMed ID: 30396514
[TBL] [Abstract][Full Text] [Related]
13. Global update: Japan.
Sipp D
Regen Med; 2011 Nov; 6(6 Suppl):160-2. PubMed ID: 21999281
[TBL] [Abstract][Full Text] [Related]
14. Regenerative medicine legislation in Japan for fast provision of cell therapy products.
Fujita Y; Kawamoto A
Clin Pharmacol Ther; 2016 Jan; 99(1):26-9. PubMed ID: 26482927
[TBL] [Abstract][Full Text] [Related]
15. Trends in the stem cell and regenerative medicine industry.
Ilic D
Regen Med; 2012 Sep; 7(5):645-8. PubMed ID: 22954435
[TBL] [Abstract][Full Text] [Related]
16. [Current status of the regulation and development of cell therapy products in Japan].
Igarashi Y; Sato Y
Nihon Yakurigaku Zasshi; 2018; 151(6):254-259. PubMed ID: 29887575
[TBL] [Abstract][Full Text] [Related]
17. Insurance systems and reimbursement concerning research and development of regenerative medicine in Japan.
Okada K; Miyata T; Sawa Y
Regen Med; 2017 Mar; 12(2):179-186. PubMed ID: 28244828
[TBL] [Abstract][Full Text] [Related]
18. Establishment of the National Consortium for Regenerative Medicine and National Regenerative Medicine Database in Japan.
Okada K; Sato Y; Sugiyama D; Sawa Y
Clin Ther; 2018 Jul; 40(7):1076-1083. PubMed ID: 29958729
[TBL] [Abstract][Full Text] [Related]
19. Navigating the U.S. Food and Drug Administration's Regulatory Science initiative: an imperative for stem cell research and regenerative medicine advocates.
Jakimo AL
Stem Cells Dev; 2013 Dec; 22 Suppl 1(Suppl 1):73-8. PubMed ID: 24304080
[No Abstract] [Full Text] [Related]
20. Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions, 1 January-28 February 2017.
Ilic D; Yau S
Regen Med; 2017 Apr; 12(4):321-330. PubMed ID: 28621222
[No Abstract] [Full Text] [Related]
[Next] [New Search]
